Drugs that contain Oxymetazoline Hydrochloride; Tetracaine Hydrochloride
1. List of Kovanaze drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9308191 | ST RENATUS | Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration |
Apr, 2030
(6 years from now) | |
| US8580282 | ST RENATUS | Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration |
Apr, 2030
(6 years from now) | |
Do you want to check out KOVANAZE patents from before 2022?
Market Authorisation Date: 29 June, 2016
Treatment: Method of anesthetizing at least a portion of the maxillary dental arch
Dosage: SPRAY, METERED;NASAL
More Information on Dosage
KOVANAZE family patents
10
United States
3
Japan
2
China
2
South Africa
2
New Zealand
2
Australia
2
Korea, Republic of
1
Canada
1
Mexico
1
Brazil
1
EA
1
Denmark
1
Portugal
1
Spain
1
Poland
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic